Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Mei Yi

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Cancer Communications (London, England)|July 5, 2023
Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trialQing Shi, Yang He, Hong-Mei Yi, et al.
Oncotarget|April 28, 2015
Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signalingQiu-Yan He, Hong-Mei Yi, Hong Yi, et al.
Blood Cancer Journal|March 30, 2022
Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implicationYu-Jia Huo, Peng-Peng Xu, Di Fu, et al.
Frontiers in Oncology|October 24, 2022
Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphomaMeng-Ke Liu, Li-Li Cheng, Hong-Mei Yi, et al.
Blood|May 21, 2026
N6-methyladenosine reader IGF2BP2 in T-cell lymphomaSong Hu, Yao Qin, Hong-Mei Yi, et al.
Oncotarget|August 29, 2015
MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathwayJia-Quan Qu, Hong-Mei Yi, Xu Ye, et al.
Blood Advances|January 3, 2024
Biological signatures of the International Prognostic Index in diffuse large B-cell lymphomaYue Wang, Qing Shi, Zi-Yang Shi, et al.
Molecular Cancer Therapeutics|August 26, 2015
MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT SignalingJia-Quan Qu, Hong-Mei Yi, Xu Ye, et al.
Clinical and Translational Medicine|July 20, 2022
Integrative genome-wide chromatin accessibility and transcriptome profiling of diffuse large B-cell lymphomaYing Fang, Mu-Chen Zhang, Peng-Peng Xu, et al.
International Journal of Biological Sciences|August 8, 2024
<i>KMT2D</i> mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axisQing-Xiao Liu, Yue Zhu, Hong-Mei Yi, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cancer Communications (London, England)|July 5, 2023
Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trialQing Shi, Yang He, Hong-Mei Yi, et al.
Oncotarget|April 28, 2015
Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signalingQiu-Yan He, Hong-Mei Yi, Hong Yi, et al.
Blood Cancer Journal|March 30, 2022
Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implicationYu-Jia Huo, Peng-Peng Xu, Di Fu, et al.
Frontiers in Oncology|October 24, 2022
Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphomaMeng-Ke Liu, Li-Li Cheng, Hong-Mei Yi, et al.
Blood|May 21, 2026
N6-methyladenosine reader IGF2BP2 in T-cell lymphomaSong Hu, Yao Qin, Hong-Mei Yi, et al.
Oncotarget|August 29, 2015
MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathwayJia-Quan Qu, Hong-Mei Yi, Xu Ye, et al.
Blood Advances|January 3, 2024
Biological signatures of the International Prognostic Index in diffuse large B-cell lymphomaYue Wang, Qing Shi, Zi-Yang Shi, et al.
Molecular Cancer Therapeutics|August 26, 2015
MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT SignalingJia-Quan Qu, Hong-Mei Yi, Xu Ye, et al.
Clinical and Translational Medicine|July 20, 2022
Integrative genome-wide chromatin accessibility and transcriptome profiling of diffuse large B-cell lymphomaYing Fang, Mu-Chen Zhang, Peng-Peng Xu, et al.
International Journal of Biological Sciences|August 8, 2024
<i>KMT2D</i> mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axisQing-Xiao Liu, Yue Zhu, Hong-Mei Yi, et al.
Pageof 5